Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA; Institute for BioNanotechnology in Medicine, Northwestern University, Chicago, IL 60611, USA.
Acta Biomater. 2013 Nov;9(11):8983-90. doi: 10.1016/j.actbio.2013.07.005. Epub 2013 Jul 12.
Increasing interest in using soy biomaterials for tissue engineering applications has prompted investigation into the in vivo biocompatibility of soy implants. In this study, the biocompatibility of soy protein scaffolds fabricated using freeze-drying and 3-D printing was assessed using a subcutaneous implant model in BALB/c mice. The main objectives of this study were: (1) to compare soy protein with bovine collagen, a well-characterized natural protein implant, by implanting scaffolds of the same protein weight, and (2) to observe the effects of soy scaffold microstructure and amount of protein loading, which also alters the degradation properties, on the acute and humoral immune responses towards soy. Results showed that freeze-dried soy scaffolds fully degraded after 14 days, whereas collagen scaffolds (of the same protein weight) remained intact for 56 days. Furthermore, Masson's trichrome staining showed little evidence of damage or fibrosis at the soy implant site. Scaffolds of higher soy protein content, however, were still present after 56 days. H&E staining revealed that macrophage infiltration was hindered in the denser bioplotted soy scaffolds, causing slower degradation. Analysis of soy-specific antibodies in mouse serum after implantation revealed levels of IgG1 that correlated with higher scaffold weight and protein density. However, no soy-specific IgE was detected, indicating the absence of an allergic response to the soy implants. These results demonstrate that soy protein could be an acceptable biocompatible implant for tissue regeneration, and that scaffold porosity, soy protein density and scaffold degradation rate significantly affect the acute and humoral immune response.
越来越多的人对将大豆生物材料用于组织工程应用感兴趣,这促使人们对大豆植入物的体内生物相容性进行了研究。在这项研究中,使用皮下植入模型在 BALB/c 小鼠中评估了使用冷冻干燥和 3D 打印制造的大豆蛋白支架的生物相容性。本研究的主要目的是:(1)通过植入相同蛋白重量的支架,将大豆蛋白与牛胶原蛋白(一种经过充分研究的天然蛋白植入物)进行比较;(2)观察大豆支架的微观结构和蛋白负载量的影响,这也会改变降解特性,从而影响对大豆的急性和体液免疫反应。结果表明,冻干大豆支架在 14 天后完全降解,而胶原蛋白支架(相同蛋白重量)在 56 天后仍保持完整。此外,Masson 三色染色显示大豆植入部位几乎没有损伤或纤维化的证据。然而,在 56 天后,仍存在更高含量大豆蛋白的支架。H&E 染色显示,在更密集的生物绘制大豆支架中,巨噬细胞浸润受阻,导致降解速度较慢。植入后在小鼠血清中分析大豆特异性抗体表明,与更高支架重量和蛋白密度相关的 IgG1 水平。然而,没有检测到大豆特异性 IgE,表明对大豆植入物没有过敏反应。这些结果表明,大豆蛋白可能是一种可接受的组织再生生物相容性植入物,并且支架的孔隙率、大豆蛋白密度和支架降解速率会显著影响急性和体液免疫反应。